+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
ECCO2R Devices Market - Global Forecast 2026-2032- Product Image
ECCO2R Devices Market - Global Forecast 2026-2032- Product Image
Sale

ECCO2R Devices Market - Global Forecast 2026-2032

  • Report

  • 182 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6142510
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The ECCO₂R Devices Market is projected to reach USD 500.47 Million in 2026. It is expected to continue growing at a CAGR of 10.46%, reaching USD 914.77 Million by 2032.

ECCO₂R Devices: Executive Summary and Strategic Context

Extracorporeal carbon dioxide removal (ECCO₂R) devices support partial removal of carbon dioxide from blood outside the body, generally with the aim of reducing ventilatory burden in selected patients. Their clinical relevance is linked to situations where conventional ventilation must be limited or optimized, including severe respiratory failure and challenges associated with lung-protective ventilation. Adoption depends on clinical evidence, patient-selection protocols, device safety, workforce capability, reimbursement, and intensive-care infrastructure.

Clinical Integration Is Shifting Toward Targeted, Protocol-Driven Use

The ECCO₂R landscape is being shaped by efforts to integrate extracorporeal support into clearly defined treatment pathways rather than treating it as a standalone technology. Key shifts include greater emphasis on patient selection, anticoagulation management, vascular-access safety, monitoring requirements, multidisciplinary decision-making, and standardized escalation and weaning criteria. Evidence generation increasingly needs to demonstrate not only physiological carbon-dioxide clearance but also clinically meaningful outcomes, operational feasibility, and acceptable complication profiles.

Artificial Intelligence Can Strengthen Monitoring Without Replacing Clinical Judgment

Artificial intelligence may support ECCO₂R programs through trend analysis, early detection of abnormal pressure or flow patterns, prediction of circuit issues, decision support for ventilator adjustments, and integration of extracorporeal data with laboratory and physiological measurements. These applications require high-quality, well-labeled clinical data and robust validation across devices, hospitals, and patient populations. Human oversight remains essential because algorithmic recommendations must account for bleeding risk, hemodynamic status, vascular access, infection concerns, and the patient’s broader treatment objectives.

Regional Insights: Infrastructure and Evidence Shape Adoption Differently

North America is characterized by advanced critical-care infrastructure, specialist centers, and active scrutiny of clinical evidence and reimbursement. Latin America faces greater variation in access to extracorporeal expertise, equipment, and financing, making training and referral networks important. Europe benefits from established critical-care collaboration, while national assessment and reimbursement requirements can differ across markets. The Middle East shows concentrated capabilities in major tertiary hospitals, with adoption influenced by workforce development and procurement priorities. Africa has substantial variation in intensive-care capacity, so scalable training, maintenance support, and appropriate patient-selection pathways are particularly important. Asia-Pacific combines highly developed systems with rapidly expanding critical-care capacity, creating diverse requirements for evidence, affordability, localization, and technical support.

Group Insights: Policy Alignment and Referral Capacity Are Decisive

ASEAN markets may benefit from regional knowledge exchange, shared training models, and referral pathways that address uneven intensive-care capacity. BRICS countries present varied healthcare systems and large clinical populations, with opportunities shaped by domestic manufacturing capability, evidence requirements, and access to specialist centers. The European Union emphasizes cross-border clinical standards, health-technology assessment, and coordinated regulation, while national implementation remains important. G7 systems generally have strong research and critical-care infrastructure but demand rigorous evidence, safety monitoring, and economic justification. GCC countries often have concentrated tertiary-care capabilities and can advance adoption through specialist training and integrated procurement. NATO members span diverse health systems, but interoperability, emergency preparedness, and critical-care readiness can support collaborative standards and training.

Country Insights: National Capacity Determines Practical Deployment

Australia’s specialized critical-care network supports evidence-led evaluation, while geography makes training and referral coordination important. Brazil and Mexico face regional variation in access and may benefit from hub-and-spoke service models. Canada’s large geography increases the importance of centralized expertise and remote support. China and India combine substantial clinical need with diverse hospital capabilities, encouraging differentiated implementation and local evidence generation. France, Germany, Italy, Spain, and the United Kingdom have sophisticated critical-care systems, but adoption depends on national guidance, assessment, reimbursement, and center-level expertise. Japan and South Korea offer advanced hospital infrastructure with strong expectations for safety, clinical validation, and workflow integration. Russia’s deployment environment is influenced by access to specialized equipment, critical-care resources, and domestic support capabilities. In the United States, specialist centers, clinical research, regulatory expectations, and payer considerations are central to adoption.

Action Priorities for Leaders: Build Evidence, Capability, and Safe Workflows

Industry leaders should define the patient populations and clinical pathways in which ECCO₂R provides a credible benefit, then generate evidence using transparent endpoints that include safety, resource use, and patient outcomes. Programs should invest in structured training for physicians, nurses, perfusion specialists, and respiratory therapists; standardized anticoagulation and vascular-access protocols; and continuous quality monitoring. Partnerships with hospitals should focus on implementation science, referral coordination, service support, and data interoperability. Artificial-intelligence features should be introduced incrementally, with prospective validation, explainability, cybersecurity controls, and clear escalation to clinicians. Regional strategies should reflect differences in infrastructure, reimbursement, workforce availability, and maintenance capacity rather than assuming a uniform adoption model.

Research Methodology: Evidence-Based Assessment of ECCO₂R Device Adoption

This executive summary is based on a structured assessment of ECCO₂R devices as a clinical-technology category. The approach considers the technology’s clinical purpose, treatment pathways, implementation requirements, safety considerations, artificial-intelligence applications, and differences in healthcare infrastructure across the specified regions, groups, and countries. Interpretation prioritizes verifiable clinical, regulatory, operational, and policy considerations. It excludes market estimates, market sizing, market shares, forecasts, and company-specific claims, and treats regional and country comparisons as qualitative assessments of enabling conditions and constraints.

Conclusion: Responsible Integration Is the Core Strategic Opportunity

ECCO₂R devices occupy a specialized role within advanced respiratory and extracorporeal care. Their long-term relevance will depend on selecting appropriate patients, demonstrating meaningful clinical value, controlling complications, and embedding use within trained multidisciplinary teams. Regional and national differences in infrastructure require adaptable implementation models, while artificial intelligence can improve surveillance and decision support when validated responsibly. Leaders who combine rigorous evidence generation with workforce development, interoperability, and patient-safety governance will be best positioned to support appropriate clinical integration.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. ECCO2R Devices Market, by Product Type
7.1. Introduction
7.2. Membrane Lung Devices
7.2.1. Reusable
7.2.2. Single Use
7.3. Respiratory Dialysis Systems
7.3.1. Direct Veno-Venous Systems
7.3.2. Veno-Arterial Systems
8. ECCO2R Devices Market, by Technology
8.1. Introduction
8.2. Passive Systems
8.3. Pump Driven Systems
9. ECCO2R Devices Market, by Blood Flow Rate
9.1. Introduction
9.2. High Flow
9.3. Low Flow
9.4. Moderate Flow
10. ECCO2R Devices Market, by Application
10.1. Introduction
10.2. Ards
10.3. Copd
10.4. Covid-19 Related Ards
11. ECCO2R Devices Market, by End User
11.1. Introduction
11.2. Ambulatory Care Facilities
11.3. Hospitals
11.4. Specialized Respiratory Clinics
12. ECCO2R Devices Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. ECCO2R Devices Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. ECCO2R Devices Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Abbott Laboratories
16.2. Abiomed, Inc.
16.3. Aferetica S.r.l
16.4. ALung Technologies, Inc.
16.5. B. Braun Melsungen AG
16.6. Baxter International Inc.
16.7. Braile Biomedica
16.8. CytoSorbents Corporation
16.9. ESTOR S.P.A
16.10. Eurosets S.r.l.
16.11. Fresenius Medical Care AG & Co. KGaA
16.12. Getinge AB
16.13. Hemovent GmbH
16.14. Infomed SA
16.15. LivaNova PLC
16.16. Maquet Cardiopulmonary GmbH
16.17. Medica S.p.A
16.18. Medtronic plc
16.19. Nipro Corporation
16.20. Novalung GmbH
16.21. Origen Biomedical, Inc.
16.22. Terumo Corporation
16.23. Toray Medical Co., Ltd.
16.24. X-COR Therapeutics
16.25. Xenios AG
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global ECCO2R Devices Market, Years Considered for the Study
FIGURE 2. Global ECCO2R Devices Market, Research Design
FIGURE 3. Global ECCO2R Devices Market, Research Framework
FIGURE 4. Global ECCO2R Devices Market, Data Triangulation
FIGURE 5. Global ECCO2R Devices Market Size, 2017-2032 (USD Million)
FIGURE 6. Global ECCO2R Devices Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global ECCO2R Devices Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global ECCO2R Devices Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 9. Global ECCO2R Devices Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global ECCO2R Devices Market Size, by Blood Flow Rate, 2025 vs 2032 (%)
FIGURE 11. Global ECCO2R Devices Market Size, by Blood Flow Rate, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global ECCO2R Devices Market Size, by Application, 2025 vs 2032 (%)
FIGURE 13. Global ECCO2R Devices Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global ECCO2R Devices Market Size, by End User, 2025 vs 2032 (%)
FIGURE 15. Global ECCO2R Devices Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global ECCO2R Devices Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global ECCO2R Devices Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global ECCO2R Devices Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global ECCO2R Devices Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global ECCO2R Devices Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global ECCO2R Devices Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global ECCO2R Devices Market Segmentation & Coverage
TABLE 2. Global ECCO2R Devices Market Size, 2017-2032 (USD Million)
TABLE 3. Global ECCO2R Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Membrane Lung Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Membrane Lung Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Membrane Lung Devices Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Reusable Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Reusable Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Reusable Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Single Use Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Single Use Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Single Use Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Respiratory Dialysis Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Respiratory Dialysis Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Respiratory Dialysis Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Direct Veno-Venous Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Direct Veno-Venous Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Direct Veno-Venous Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Veno-Arterial Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Veno-Arterial Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Veno-Arterial Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global ECCO2R Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 23. Global Passive Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Passive Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Passive Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Pump Driven Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Pump Driven Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Pump Driven Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global ECCO2R Devices Market Size, by Blood Flow Rate, 2017-2032 (USD Million)
TABLE 30. Global High Flow Market Size, by Region, 2017-2032 (USD Million)
TABLE 31. Global High Flow Market Size, by Group, 2017-2032 (USD Million)
TABLE 32. Global High Flow Market Size, by Country, 2017-2032 (USD Million)
TABLE 33. Global Low Flow Market Size, by Region, 2017-2032 (USD Million)
TABLE 34. Global Low Flow Market Size, by Group, 2017-2032 (USD Million)
TABLE 35. Global Low Flow Market Size, by Country, 2017-2032 (USD Million)
TABLE 36. Global Moderate Flow Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Moderate Flow Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Moderate Flow Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global ECCO2R Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 40. Global Ards Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Ards Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Ards Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Copd Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Copd Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Copd Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Covid-19 Related Ards Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Covid-19 Related Ards Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Covid-19 Related Ards Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global ECCO2R Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 50. Global Ambulatory Care Facilities Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Ambulatory Care Facilities Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Ambulatory Care Facilities Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Specialized Respiratory Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Specialized Respiratory Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Specialized Respiratory Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global ECCO2R Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Asia-Pacific ECCO2R Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Asia-Pacific ECCO2R Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 62. Asia-Pacific ECCO2R Devices Market Size, by Membrane Lung Devices, 2017-2032 (USD Million)
TABLE 63. Asia-Pacific ECCO2R Devices Market Size, by Respiratory Dialysis Systems, 2017-2032 (USD Million)
TABLE 64. Asia-Pacific ECCO2R Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 65. Asia-Pacific ECCO2R Devices Market Size, by Blood Flow Rate, 2017-2032 (USD Million)
TABLE 66. Asia-Pacific ECCO2R Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 67. Asia-Pacific ECCO2R Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 68. North America ECCO2R Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. North America ECCO2R Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 70. North America ECCO2R Devices Market Size, by Membrane Lung Devices, 2017-2032 (USD Million)
TABLE 71. North America ECCO2R Devices Market Size, by Respiratory Dialysis Systems, 2017-2032 (USD Million)
TABLE 72. North America ECCO2R Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 73. North America ECCO2R Devices Market Size, by Blood Flow Rate, 2017-2032 (USD Million)
TABLE 74. North America ECCO2R Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 75. North America ECCO2R Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 76. Latin America ECCO2R Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 77. Latin America ECCO2R Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 78. Latin America ECCO2R Devices Market Size, by Membrane Lung Devices, 2017-2032 (USD Million)
TABLE 79. Latin America ECCO2R Devices Market Size, by Respiratory Dialysis Systems, 2017-2032 (USD Million)
TABLE 80. Latin America ECCO2R Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 81. Latin America ECCO2R Devices Market Size, by Blood Flow Rate, 2017-2032 (USD Million)
TABLE 82. Latin America ECCO2R Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 83. Latin America ECCO2R Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 84. Europe ECCO2R Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 85. Europe ECCO2R Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 86. Europe ECCO2R Devices Market Size, by Membrane Lung Devices, 2017-2032 (USD Million)
TABLE 87. Europe ECCO2R Devices Market Size, by Respiratory Dialysis Systems, 2017-2032 (USD Million)
TABLE 88. Europe ECCO2R Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 89. Europe ECCO2R Devices Market Size, by Blood Flow Rate, 2017-2032 (USD Million)
TABLE 90. Europe ECCO2R Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 91. Europe ECCO2R Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 92. Middle East ECCO2R Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 93. Middle East ECCO2R Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 94. Middle East ECCO2R Devices Market Size, by Membrane Lung Devices, 2017-2032 (USD Million)
TABLE 95. Middle East ECCO2R Devices Market Size, by Respiratory Dialysis Systems, 2017-2032 (USD Million)
TABLE 96. Middle East ECCO2R Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 97. Middle East ECCO2R Devices Market Size, by Blood Flow Rate, 2017-2032 (USD Million)
TABLE 98. Middle East ECCO2R Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 99. Middle East ECCO2R Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 100. Africa ECCO2R Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 101. Africa ECCO2R Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 102. Africa ECCO2R Devices Market Size, by Membrane Lung Devices, 2017-2032 (USD Million)
TABLE 103. Africa ECCO2R Devices Market Size, by Respiratory Dialysis Systems, 2017-2032 (USD Million)
TABLE 104. Africa ECCO2R Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 105. Africa ECCO2R Devices Market Size, by Blood Flow Rate, 2017-2032 (USD Million)
TABLE 106. Africa ECCO2R Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 107. Africa ECCO2R Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 108. Global ECCO2R Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 109. ASEAN ECCO2R Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 110. ASEAN ECCO2R Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 111. ASEAN ECCO2R Devices Market Size, by Membrane Lung Devices, 2017-2032 (USD Million)
TABLE 112. ASEAN ECCO2R Devices Market Size, by Respiratory Dialysis Systems, 2017-2032 (USD Million)
TABLE 113. ASEAN ECCO2R Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 114. ASEAN ECCO2R Devices Market Size, by Blood Flow Rate, 2017-2032 (USD Million)
TABLE 115. ASEAN ECCO2R Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 116. ASEAN ECCO2R Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 117. GCC ECCO2R Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 118. GCC ECCO2R Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 119. GCC ECCO2R Devices Market Size, by Membrane Lung Devices, 2017-2032 (USD Million)
TABLE 120. GCC ECCO2R Devices Market Size, by Respiratory Dialysis Systems, 2017-2032 (USD Million)
TABLE 121. GCC ECCO2R Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 122. GCC ECCO2R Devices Market Size, by Blood Flow Rate, 2017-2032 (USD Million)
TABLE 123. GCC ECCO2R Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 124. GCC ECCO2R Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 125. European Union ECCO2R Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 126. European Union ECCO2R Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 127. European Union ECCO2R Devices Market Size, by Membrane Lung Devices, 2017-2032 (USD Million)
TABLE 128. European Union ECCO2R Devices Market Size, by Respiratory Dialysis Systems, 2017-2032 (USD Million)
TABLE 129. European Union ECCO2R Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 130. European Union ECCO2R Devices Market Size, by Blood Flow Rate, 2017-2032 (USD Million)
TABLE 131. European Union ECCO2R Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 132. European Union ECCO2R Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 133. BRICS ECCO2R Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 134. BRICS ECCO2R Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 135. BRICS ECCO2R Devices Market Size, by Membrane Lung Devices, 2017-2032 (USD Million)
TABLE 136. BRICS ECCO2R Devices Market Size, by Respiratory Dialysis Systems, 2017-2032 (USD Million)
TABLE 137. BRICS ECCO2R Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 138. BRICS ECCO2R Devices Market Size, by Blood Flow Rate, 2017-2032 (USD Million)
TABLE 139. BRICS ECCO2R Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 140. BRICS ECCO2R Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 141. G7 ECCO2R Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 142. G7 ECCO2R Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 143. G7 ECCO2R Devices Market Size, by Membrane Lung Devices, 2017-2032 (USD Million)
TABLE 144. G7 ECCO2R Devices Market Size, by Respiratory Dialysis Systems, 2017-2032 (USD Million)
TABLE 145. G7 ECCO2R Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 146. G7 ECCO2R Devices Market Size, by Blood Flow Rate, 2017-2032 (USD Million)
TABLE 147. G7 ECCO2R Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 148. G7 ECCO2R Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 149. NATO ECCO2R Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 150. NATO ECCO2R Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 151. NATO ECCO2R Devices Market Size, by Membrane Lung Devices, 2017-2032 (USD Million)
TABLE 152. NATO ECCO2R Devices Market Size, by Respiratory Dialysis Systems, 2017-2032 (USD Million)
TABLE 153. NATO ECCO2R Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 154. NATO ECCO2R Devices Market Size, by Blood Flow Rate, 2017-2032 (USD Million)
TABLE 155. NATO ECCO2R Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 156. NATO ECCO2R Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 157. Global ECCO2R Devices Market Size, by Country, 2017-2032 (USD Million)
TABLE 158. United States ECCO2R Devices Market Size, 2017-2032 (USD Million)
TABLE 159. United States ECCO2R Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 160. United States ECCO2R Devices Market Size, by Membrane Lung Devices, 2017-2032 (USD Million)
TABLE 161. United States ECCO2R Devices Market Size, by Respiratory Dialysis Systems, 2017-2032 (USD Million)
TABLE 162. United States ECCO2R Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 163. United States ECCO2R Devices Market Size, by Blood Flow Rate, 2017-2032 (USD Million)
TABLE 164. United States ECCO2R Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 165. United States ECCO2R Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 166. Canada ECCO2R Devices Market Size, 2017-2032 (USD Million)
TABLE 167. Canada ECCO2R Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 168. Canada ECCO2R Devices Market Size, by Membrane Lung Devices, 2017-2032 (USD Million)
TABLE 169. Canada ECCO2R Devices Market Size, by Respiratory Dialysis Systems, 2017-2032 (USD Million)
TABLE 170. Canada ECCO2R Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 171. Canada ECCO2R Devices Market Size, by Blood Flow Rate, 2017-2032 (USD Million)
TABLE 172. Canada ECCO2R Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 173. Canada ECCO2R Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 174. Mexico ECCO2R Devices Market Size, 2017-2032 (USD Million)
TABLE 175. Mexico ECCO2R Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 176. Mexico ECCO2R Devices Market Size, by Membrane Lung Devices, 2017-2032 (USD Million)
TABLE 177. Mexico ECCO2R Devices Market Size, by Respiratory Dialysis Systems, 2017-2032 (USD Million)
TABLE 178. Mexico ECCO2R Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 179. Mexico ECCO2R Devices Market Size, by Blood Flow Rate, 2017-2032 (USD Million)
TABLE 180. Mexico ECCO2R Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 181. Mexico ECCO2R Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 182. Brazil ECCO2R Devices Market Size, 2017-2032 (USD Million)
TABLE 183. Brazil ECCO2R Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 184. Brazil ECCO2R Devices Market Size, by Membrane Lung Devices, 2017-2032 (USD Million)
TABLE 185. Brazil ECCO2R Devices Market Size, by Respiratory Dialysis Systems, 2017-2032 (USD Million)
TABLE 186. Brazil ECCO2R Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 187. Brazil ECCO2R Devices Market Size, by Blood Flow Rate, 2017-2032 (USD Million)
TABLE 188. Brazil ECCO2R Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 189. Brazil ECCO2R Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 190. United Kingdom ECCO2R Devices Market Size, 2017-2032 (USD Million)
TABLE 191. United Kingdom ECCO2R Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 192. United Kingdom ECCO2R Devices Market Size, by Membrane Lung Devices, 2017-2032 (USD Million)
TABLE 193. United Kingdom ECCO2R Devices Market Size, by Respiratory Dialysis Systems, 2017-2032 (USD Million)
TABLE 194. United Kingdom ECCO2R Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 195. United Kingdom ECCO2R Devices Market Size, by Blood Flow Rate, 2017-2032 (USD Million)
TABLE 196. United Kingdom ECCO2R Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 197. United Kingdom ECCO2R Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 198. Germany ECCO2R Devices Market Size, 2017-2032 (USD Million)
TABLE 199. Germany ECCO2R Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 200. Germany ECCO2R Devices Market Size, by Membrane Lung Devices, 2017-2032 (USD Million)
TABLE 201. Germany ECCO2R Devices Market Size, by Respiratory Dialysis Systems, 2017-2032 (USD Million)
TABLE 202. Germany ECCO2R Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 203. Germany ECCO2R Devices Market Size, by Blood Flow Rate, 2017-2032 (USD Million)
TABLE 204. Germany ECCO2R Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 205. Germany ECCO2R Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 206. France ECCO2R Devices Market Size, 2017-2032 (USD Million)
TABLE 207. France ECCO2R Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 208. France ECCO2R Devices Market Size, by Membrane Lung Devices, 2017-2032 (USD Million)
TABLE 209. France ECCO2R Devices Market Size, by Respiratory Dialysis Systems, 2017-2032 (USD Million)
TABLE 210. France ECCO2R Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 211. France ECCO2R Devices Market Size, by Blood Flow Rate, 2017-2032 (USD Million)
TABLE 212. France ECCO2R Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 213. France ECCO2R Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 214. Russia ECCO2R Devices Market Size, 2017-2032 (USD Million)
TABLE 215. Russia ECCO2R Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 216. Russia ECCO2R Devices Market Size, by Membrane Lung Devices, 2017-2032 (USD Million)
TABLE 217. Russia ECCO2R Devices Market Size, by Respiratory Dialysis Systems, 2017-2032 (USD Million)
TABLE 218. Russia ECCO2R Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 219. Russia ECCO2R Devices Market Size, by Blood Flow Rate, 2017-2032 (USD Million)
TABLE 220. Russia ECCO2R Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 221. Russia ECCO2R Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 222. Italy ECCO2R Devices Market Size, 2017-2032 (USD Million)
TABLE 223. Italy ECCO2R Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 224. Italy ECCO2R Devices Market Size, by Membrane Lung Devices, 2017-2032 (USD Million)
TABLE 225. Italy ECCO2R Devices Market Size, by Respiratory Dialysis Systems, 2017-2032 (USD Million)
TABLE 226. Italy ECCO2R Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 227. Italy ECCO2R Devices Market Size, by Blood Flow Rate, 2017-2032 (USD Million)
TABLE 228. Italy ECCO2R Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 229. Italy ECCO2R Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 230. Spain ECCO2R Devices Market Size, 2017-2032 (USD Million)
TABLE 231. Spain ECCO2R Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 232. Spain ECCO2R Devices Market Size, by Membrane Lung Devices, 2017-2032 (USD Million)
TABLE 233. Spain ECCO2R Devices Market Size, by Respiratory Dialysis Systems, 2017-2032 (USD Million)
TABLE 234. Spain ECCO2R Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 235. Spain ECCO2R Devices Market Size, by Blood Flow Rate, 2017-2032 (USD Million)
TABLE 236. Spain ECCO2R Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 237. Spain ECCO2R Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 238. China ECCO2R Devices Market Size, 2017-2032 (USD Million)
TABLE 239. China ECCO2R Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 240. China ECCO2R Devices Market Size, by Membrane Lung Devices, 2017-2032 (USD Million)
TABLE 241. China ECCO2R Devices Market Size, by Respiratory Dialysis Systems, 2017-2032 (USD Million)
TABLE 242. China ECCO2R Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 243. China ECCO2R Devices Market Size, by Blood Flow Rate, 2017-2032 (USD Million)
TABLE 244. China ECCO2R Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 245. China ECCO2R Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 246. India ECCO2R Devices Market Size, 2017-2032 (USD Million)
TABLE 247. India ECCO2R Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 248. India ECCO2R Devices Market Size, by Membrane Lung Devices, 2017-2032 (USD Million)
TABLE 249. India ECCO2R Devices Market Size, by Respiratory Dialysis Systems, 2017-2032 (USD Million)
TABLE 250. India ECCO2R Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 251. India ECCO2R Devices Market Size, by Blood Flow Rate, 2017-2032 (USD Million)
TABLE 252. India ECCO2R Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 253. India ECCO2R Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 254. Japan ECCO2R Devices Market Size, 2017-2032 (USD Million)
TABLE 255. Japan ECCO2R Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 256. Japan ECCO2R Devices Market Size, by Membrane Lung Devices, 2017-2032 (USD Million)
TABLE 257. Japan ECCO2R Devices Market Size, by Respiratory Dialysis Systems, 2017-2032 (USD Million)
TABLE 258. Japan ECCO2R Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 259. Japan ECCO2R Devices Market Size, by Blood Flow Rate, 2017-2032 (USD Million)
TABLE 260. Japan ECCO2R Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 261. Japan ECCO2R Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 262. Australia ECCO2R Devices Market Size, 2017-2032 (USD Million)
TABLE 263. Australia ECCO2R Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 264. Australia ECCO2R Devices Market Size, by Membrane Lung Devices, 2017-2032 (USD Million)
TABLE 265. Australia ECCO2R Devices Market Size, by Respiratory Dialysis Systems, 2017-2032 (USD Million)
TABLE 266. Australia ECCO2R Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 267. Australia ECCO2R Devices Market Size, by Blood Flow Rate, 2017-2032 (USD Million)
TABLE 268. Australia ECCO2R Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 269. Australia ECCO2R Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 270. South Korea ECCO2R Devices Market Size, 2017-2032 (USD Million)
TABLE 271. South Korea ECCO2R Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 272. South Korea ECCO2R Devices Market Size, by Membrane Lung Devices, 2017-2032 (USD Million)
TABLE 273. South Korea ECCO2R Devices Market Size, by Respiratory Dialysis Systems, 2017-2032 (USD Million)
TABLE 274. South Korea ECCO2R Devices Market Size, by Technology, 2017-2032 (USD Million)
TABLE 275. South Korea ECCO2R Devices Market Size, by Blood Flow Rate, 2017-2032 (USD Million)
TABLE 276. South Korea ECCO2R Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 277. South Korea ECCO2R Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 278. Global ECCO2R Devices Market Share, by Key Player, 2025
TABLE 279. Global ECCO2R Devices Market, Key Experts

Companies Mentioned

  • Abbott Laboratories
  • Abiomed, Inc.
  • Aferetica S.r.l
  • ALung Technologies, Inc.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Braile Biomedica
  • CytoSorbents Corporation
  • ESTOR S.P.A
  • Eurosets S.r.l.
  • Fresenius Medical Care AG & Co. KGaA
  • Getinge AB
  • Hemovent GmbH
  • Infomed SA
  • LivaNova PLC
  • Maquet Cardiopulmonary GmbH
  • Medica S.p.A
  • Medtronic plc
  • Nipro Corporation
  • Novalung GmbH
  • Origen Biomedical, Inc.
  • Terumo Corporation
  • Toray Medical Co., Ltd.
  • X-COR Therapeutics
  • Xenios AG

Related Topics

Related Reports

Extracorporeal CO2 Removal Devices Market - Global Forecast 2026-2032 - Product Image

Extracorporeal CO2 Removal Devices Market - Global Forecast 2026-2032

  • Report
  • 186 Pages
  • Global
From
Extracorporeal CO2 Removal Devices - Global Strategic Business Report - Product Image

Extracorporeal CO2 Removal Devices - Global Strategic Business Report

  • Report
  • 193 Pages
  • Global
From
Extracorporeal CO2 Removal Devices Market Outlook 2026-2034: Market Share, and Growth Analysis - Product Image

Extracorporeal CO2 Removal Devices Market Outlook 2026-2034: Market Share, and Growth Analysis

  • Report
  • 160 Pages
  • Global
From
Oxygenator Market - Global Forecast 2026-2032 - Product Image

Oxygenator Market - Global Forecast 2026-2032

  • Report
  • 194 Pages
  • Global
From
Extracorporeal Membrane Oxygenation (ECMO) Machine - Global Strategic Business Report - Product Image

Extracorporeal Membrane Oxygenation (ECMO) Machine - Global Strategic Business Report

  • Report
  • 477 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.